
|Articles|March 1, 2002
Anticonvulsant additive reduces herpetic pain
New Orleans - Data from an open-label study suggest that the anticonvulsant drug gabapentin (Neurontin) added to antiviral treatment during acute herpes zoster infection may further reduce the duration and severity of postherpetic neuralgia, Mathijs H. Brentjens, M.S., M.D., reported at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
Top 5 Articles of the Week: December 7-12
4
Dermatology Times Spot Test: December 14, 2025
5


















